Valneva

Trophy
#Awards #Immunology / Virology & Vaccines #Scotland #Valneva

Two wins for vaccine company at Scotland’s Life Sciences Awards

Valneva Scotland scooped two prizes at Scotland’s Life Sciences Awards 2024, including the award for Innovation – Pharma Services And Drug Discovery, in a ceremony on 14 March in Glasgow. Valneva Scotland is focused on vaccines for infectious diseases with significant unmet medical needs. Read More

#News

Mosquito
#Chikungunya virus #FDA #Immunology / Virology & Vaccines #Valneva

FDA approves world’s first chikungunya vaccine

The US Food and Drug Administration (FDA) has approved Ixchiq, Valneva’s single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus (CHIKV). The vaccine is indicated in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. Read More

#News #Trending News